How to appeal a Humana kidney disease — ckd, esrd, igan, adpkd denial

The framework that applies to your appeal

Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).

Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.

What Humana's policy requires for kidney disease — ckd, esrd, igan, adpkd

Cited policy: Humana MA — ESRD anemia coverage (ESAs bundled in PPS)

Hgb <10 + iron-replete (TSAT >=20%, ferritin >=200). FDA boxed warning vs Hgb >=11.

How Humana denies kidney disease — ckd, esrd, igan, adpkd — and how to counter it

Where Humana pushes back: 1) Hgb >=10 on most recent; 2) Iron not repleted; 3) Mircera vs Aranesp formulary preference.

Counter-arguments that hold up: FDA label initiates ESA/HIF-PHI when Hgb <10 with documented decline trajectory and transfusion-avoidance rationale. Iron studies provided (TSAT, ferritin). For Mircera: monthly dosing advantage (vs weekly Aranesp/Procrit) — adherence rationale. Vafseo + Jesduvroq received TDAPA — covered as dialysis bundle add-on.

What Humana typically denies for kidney disease — ckd, esrd, igan, adpkd

Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For kidney disease — ckd, esrd, igan, adpkd, expect:

• MA plan step therapy on Part B drugs
• Skilled nursing facility days
• Prior auth on specialty drugs
• OON emergency reduction

Treatments most often denied in this category

These are the kidney disease — ckd, esrd, igan, adpkd treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Tarpeyo (IgAN)
• Filspari
• Farxiga (CKD)
• Jardiance (CKD)
• Kerendia
• Jynarque (ADPKD)

How to submit the appeal to Humana

1. Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
3. File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.